Literature DB >> 18777089

Gene expression in normotopic and heterotopic human bone: increased level of SP7 mRNA in pathological tissue.

C Chauveau1, O Broux, C Delecourt, P Hardouin, J Jeanfils, J C Devedjian.   

Abstract

Head injury-induced heterotopic ossification (HO) develops at vicinity of joints and in severe cases requires surgical intervention. Our previous study demonstrated high mRNA levels of osteocalcin (OC), type 1 collagen (COL1), osteonectin and RUNX2/CBFA1 in osteocytes and lining osteoblasts from non-evolutive HO compared to equivalent healthy cells from the proximal femoral shaft of patients receiving prosthesis. This allowed a first molecular characterisation of this pathological bone. The aims of this study is to extend the analysis to 10 more genes and determine those involved in the high OC mRNA level observed in pathological bone samples. RNAs were prepared from normotopic and heterotopic human bone samples digested by collagenase. After cDNA synthesis, mRNA levels were determined by real-time PCR and normalised using beta actin and glyceraldehyde-3-phosphate dehydrogenase. OSTERIX/SP7 expression was observed for the first time in human adult bone biopsies. In HO samples higher levels of SP7 (four- to sevenfold increase) and 1alpha,25-dihydroxy vitamin D(3) receptor (VDR) (two- to threefold increase) were observed compared to control samples. Moreover, SP7 level was correlated to OC and RUNX2 levels. In control samples, OC and SP7 levels were correlated. Our study further confirms that the involvement of SP7 in bone physiology is not only limited to the developmental step. Moreover, our results support the hypothesis that in HO the high level of OC expression could be due not only to an increase in RUNX2, but also in SP7 or VDR or to an imbalance in their respective activities.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18777089     DOI: 10.1007/s11010-008-9859-5

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  28 in total

1.  Mechanism of action of superactive vitamin D analogs through regulated receptor degradation.

Authors:  T Jääskeläinen; S Ryhänen; A Mahonen; H F DeLuca; P H Mäenpää
Journal:  J Cell Biochem       Date:  2000-01       Impact factor: 4.429

2.  Human and murine osteocalcin gene expression: conserved tissue restricted expression and divergent responses to 1,25-dihydroxyvitamin D3 in vivo.

Authors:  N A Sims; C P White; K L Sunn; G P Thomas; M L Drummond; N A Morrison; J A Eisman; E M Gardiner
Journal:  Mol Endocrinol       Date:  1997-10

Review 3.  Osteocalcin gene promoter: unlocking the secrets for regulation of osteoblast growth and differentiation.

Authors:  J B Lian; G S Stein; J L Stein; A J van Wijnen
Journal:  J Cell Biochem Suppl       Date:  1998

4.  DNA sequences in the rat osteocalcin gene that bind the 1,25-dihydroxyvitamin D3 receptor and confer responsiveness to 1,25-dihydroxyvitamin D3.

Authors:  M B Demay; J M Gerardi; H F DeLuca; H M Kronenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

Review 5.  Contributions of nuclear architecture and chromatin to vitamin D-dependent transcriptional control of the rat osteocalcin gene.

Authors:  J B Lian; J L Stein; G S Stein; M Montecino; A J van Wijnen; A Javed; S Gutierrez
Journal:  Steroids       Date:  2001 Mar-May       Impact factor: 2.668

6.  Osterix/Sp7 regulates mesenchymal stem cell mediated endochondral ossification.

Authors:  Lee A Kaback; Do Y Soung; Amish Naik; Nathan Smith; Edward M Schwarz; Regis J O'Keefe; Hicham Drissi
Journal:  J Cell Physiol       Date:  2008-01       Impact factor: 6.384

7.  Positive regulation of the vitamin D receptor by its cognate ligand in heterologous expression systems.

Authors:  D Santiso-Mere; T Sone; G M Hilliard; J W Pike; D P McDonnell
Journal:  Mol Endocrinol       Date:  1993-07

8.  Osterix induces osteogenic gene expression but not differentiation in primary human fetal mesenchymal stem cells.

Authors:  Hitoshi Kurata; Pascale V Guillot; Jerry Chan; Nicholas M Fisk
Journal:  Tissue Eng       Date:  2007-07

9.  Endocrine regulation of energy metabolism by the skeleton.

Authors:  Na Kyung Lee; Hideaki Sowa; Eiichi Hinoi; Mathieu Ferron; Jong Deok Ahn; Cyrille Confavreux; Romain Dacquin; Patrick J Mee; Marc D McKee; Dae Young Jung; Zhiyou Zhang; Jason K Kim; Franck Mauvais-Jarvis; Patricia Ducy; Gerard Karsenty
Journal:  Cell       Date:  2007-08-10       Impact factor: 41.582

10.  Expression of alternatively spliced isoforms of human Sp7 in osteoblast-like cells.

Authors:  Maria-athina Milona; Julie E Gough; Alasdair J Edgar
Journal:  BMC Genomics       Date:  2003-11-07       Impact factor: 3.969

View more
  2 in total

1.  Strong effect of SNP rs4988300 of the LRP5 gene on bone phenotype of Caucasian postmenopausal women.

Authors:  Péter Horváth; Bernadett Balla; János P Kósa; Bálint Tóbiás; Balázs Szili; Gyöngyi Kirschner; Gabriella Győri; Karina Kató; Péter Lakatos; István Takács
Journal:  J Bone Miner Metab       Date:  2015-03-12       Impact factor: 2.626

2.  Neurogenic heterotopic ossification in Guillain-Barre syndrome: a rare case report.

Authors:  Mecbure Nalbantoglu; Ozlem Gungor Tuncer; M Eren Acık; Zeliha Matur; Burcu Altunrende; Ebru Ozgonenel; Levent Ozgonenel
Journal:  J Musculoskelet Neuronal Interact       Date:  2020-03-03       Impact factor: 2.041

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.